Plain-English translation of NCT02328677 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Colorectal Cancer research guide →The ColoCare Study is a long-term research project following thousands of colorectal cancer patients across multiple hospitals in the United States, Germany, and other locations. Researchers are studying what helps some patients survive and thrive after treatment, and what factors predict whether cancer might come back. By tracking patients over five years and collecting blood, tissue, and health information, doctors hope to understand colorectal cancer better and personalize care in the future.
Colorectal cancer affects many people worldwide, but outcomes vary widely from patient to patient. Doctors don't yet have reliable tools to predict who will do well and who might face challenges after treatment. This study aims to identify the biological markers and life factors that influence survival and quality of life, so future patients can receive more tailored, effective care.
You likely qualify if…
You likely don't qualify if…
You would be followed for up to five years, starting at the time of your cancer diagnosis. You'll have check-in visits at 3, 6, 12, 24, 36, 48, and 60 months, where you'll complete questionnaires about your health, quality of life, and any side effects from treatment. Researchers will collect blood and tissue samples and review your medical records to track your progress. The main intensive questionnaire assessments happen at baseline, 12 months, and 5 years, with detailed medical record review at 2 and 5 years.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
United States